Company Overview and News

1
DIRTT and Iron Compass agree on board refreshment

2018-04-16 globenewswire
CALGARY, Alberta, April 16, 2018 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX:DRT), an interior construction company using technology for client-driven design and manufacturing, announces it has agreed with recommendations provided by Iron Compass, LLC to add John (Jack) Elliott and Ronald Kaplan to the board of directors of the Company (the “Board”), effective immediately.
Upvote Downvote

 
[Press] Oil and Gas Pipeline Leak Detection - Company Profiles Market Share and Recent Developments

2018-02-26 oilvoice
The natural resources of oil and gas are in limited resources and require heavy investments for a fruitful extraction. Additionally, the leakage of oil and gas often leads to substantial damage of property and sometimes life too, besides severely affecting the environment for a long term. As a result, it is paramount for the players operating in the oil and gas industry to install efficient detection methods.
Upvote Downvote

 
Why Xylem (XYL) Is a Must-Add Stock to Your Portfolio

2018-02-07 zacks
The equity universe has been witnessing an upward trend, of late, recording gains of 2.4%, 3% and 3.4% for the S&P 500, Nasdaq and Dow Jones Industrial Average, respectively, over the last three months.
Upvote Downvote

 
BRIEF-Pure Technologies Announces Securityholder And Court Approval For Arrangement

2018-01-25 reuters
* PURE TECHNOLOGIES LTD - SECURITYHOLDER AND COURT APPROVAL FOR PROPOSED ARRANGEMENT UNDER WHICH XYLEM WILL BUY CO Source text for Eikon: Further company coverage:
Upvote Downvote

 
Xylem (XYL) Displays Bright Prospects Amid Macro Headwinds

2018-01-08 zacks
On Jan 8, we issued an updated research report on premium diversified machinery company Xylem Inc. (XYL - Free Report) .
Upvote Downvote

1
BRIEF-Pure Technologies Announces Receipt Of Regulatory Approval For Arrangement

2018-01-03 reuters
* PURE TECHNOLOGIES - RECEIVED WRITTEN NOTICE FROM U.S. FTC OF EARLY TERMINATION OF WAITING PERIOD UNDER HART-SCOTT-RODINO ACT IN CONNECTION WITH ARRANGEMENT​
Upvote Downvote

 
Toronto Exchanges Stock Review, Celestica, Pure Technologies, Electrovaya, and D Box Technologies

2018-01-02 accesswire
LONDON, UK / ACCESSWIRE / January 02, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Computer Hardware industry: Celestica, Pure Technologies, Electrovaya, and D-Box Technologies. Access our complimentary up-to-the-minute research reports by becoming an online member now:
Upvote Downvote

 
Xylem's (XYL) Acquires Pure Technologies Ltd. Broker Conference Call (Transcript)

2017-12-17 seekingalpha
Good morning, and welcome to the Xylem call. [Operator Instructions]. I would now like to turn the call over to Matt Latino, Senior Director of Investor Relations. Please go ahead.
Upvote Downvote

 
Stocks making the biggest moves premarket: ADP, FIT, X, LKQ & more

2017-12-12 cnbc
Fitbit — Fitbit announced Friday it had reached a "global settlement" with former wearables maker Jawbone which ends all outstanding civil litigation. Jawbone sued Fitbit in 2015, claiming they trade secrets and market research, among other information.
Upvote Downvote

 
Calgary-based water pipeline company accepts $509M offer from New York partner

2017-12-12 ctvnews.ca
CALGARY -- A Calgary-based water pipeline technology and inspection company says it has agreed to be sold for more than half a billion dollars to New York-based Xylem Inc.
Upvote Downvote

 
Research Reports on Celestica, Pure Technologies, Electrovaya, and D Box Technologies

2017-12-04 accesswire
The S&P/TSX Composite Index lost 28.51 points, or 0.18%, to close Friday's trading session at 16,038.97. The TSX Venture Exchange gained 0.11 points, or 0.01%, to finish at 789.00.
Upvote Downvote

 
Pure Technologies' (PPEHF) CEO Jack Elliott on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Pure Technologies Ltd. (OTC:PPEHF) Q3 2017 Results Earnings Conference Call November 8, 2017 10:30 AM ET
Upvote Downvote

 
Canadian Technology Stocks Under Review, Celestica, Pure Technologies, Electrovaya, and D Box Technologies

2017-10-31 accesswire
LONDON, UK / ACCESSWIRE / October 31, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Computer Hardware industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Celestica, Pure Technologies, Electrovaya, and D-Box Technologies.
Upvote Downvote

 
Daily Coverage on Technology Stocks, Celestica, Pure Technologies, Electrovaya, and D Box Technologies

2017-09-26 accesswire
LONDON, UK / ACCESSWIRE / September 26, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Computer Hardware industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Celestica, Pure Technologies, Electrovaya, and D-Box Technologies.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...